<b>The level of diagnosis of infectious pathogenic microorganisms needs to be improved, and microbiological testing has become an industry windfall. </b>
<p> In 2017, the morbidity and mortality rates of infectious pathogenic microorganisms in China were 509.54 (1/100,000) and 1.43 (1/100,000), respectively, maintaining an upward trend. Relative to the world, the level of diagnosis and treatment of microbial infectious diseases in China is low, with HIV/TB prevalence and mortality rates of 3.6 (1/100,000) and 0.76 (1/100,000), respectively, with a large gap with developed countries. Rapid clarification of pathogens is the basis for effective infection control, and traditional microbiological testing has greatly limited its clinical use in China due to multiple steps and complex operations. New technologies such as PCR, mass spectrometry and NGS greatly complement traditional detection techniques, and microbiological testing is expected to usher in a breakthrough.</p>
<h2>SWOT Analysis</h2>
<divclass="opic large">
<imgsrc=""alt="png">
</div>
<h2>SWOT Analysis</h2>
<h3>Strengths:</h3>
<p>Device is portable</p>
<p>Practical applications</p>
<p>Real-time analysis</p>
<p>Friendly human-machine interface</p>
<h3>Weaknesses:</h3>
<p>Application of synthetic biology is new to medical services,may face rejection of consumers.</p>
<p>High cost</p>
<h3>Opportunities:</h3>
<p>Alternative device to the existing method</p>
<p>Possibility for the device to have variety quantifications。</p>
